Clinical Trials Browser

Phase 2 × Urinary Bladder Neoplasms × Oxaliplatin × Clear all

NCT05007106 2025-08-14

KEYVIBE-005

Phase 2 Completed

BreastGastrointestinalGenitourinaryGynecologicHead & Neck

Parkinson Disease 4, Autosomal Dominant Lewy Body, Squamous Cell Carcinoma of Head and Neck, Urinary Bladder Neoplasms, Uterine Cervical Neoplasms, Esophageal Neoplasms, Gallbladder Neoplasms, Carcinoma, Hepatocellular, Ovarian Neoplasms, Stomach Neoplasms, Endometrial Neoplasms, Cholangiocarcinoma, Triple Negative Breast Neoplasms

NCT00627432 2025-02-18

Gemcitabine With Or Without Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Bladder Cancer

Phase 2 Completed

Urinary Bladder Neoplasms

NCT04039867 2023-08-21

Evaluation of Oxaliplatin and Gemcitabine in Patients With Metastatic Bladder Cancer

Phase 2 Terminated

17 enrolled 9 charts

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell

NCT00004203 2013-09-05

Oxaliplatin in Treating Patients With Metastatic Bladder Cancer

Phase 2 Completed

Urinary Bladder Neoplasms

NCT00186277 2011-03-30

Phase II Study of Oxaliplatin and Taxotere in Metastatic Bladder Cancer

Phase 2 Completed

Urinary Bladder Neoplasms